Complementary alternative medicine and nuclear medicine
- 79 Downloads
Complementary alternative medicines (CAMs), including food supplements, are taken widely by patients, especially those with cancer. Others take CAMs hoping to improve fitness or prevent disease. Physicians (and patients) may not be aware of the potential side-effects and interactions of CAMs with conventional treatment. Likewise, their known physiological effects could interfere with radiopharmaceutical kinetics, producing abnormal treatment responses and diagnostic results. Nuclear medicine physicians are encouraged to question patients on their intake of CAMs when taking their history prior to radionuclide therapy or diagnosis. The potential effect of CAMs should be considered when unexpected therapeutic or diagnostic results are found.
KeywordsAlternative Complementary Therapy Diagnosis Interaction
We are grateful to Adrian Hall and Rob Williams for their comments and suggestions.
- 1.Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D: Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer. In press.Google Scholar
- 5.Food Standards Agency: Expert Group on Vitamins and Minerals. Safe upper levels for vitamins and minerals. 2003. www.foodstandards.gov.uk.Google Scholar
- 6.Natural lithium. 2003. http://www.findserenitynow.comGoogle Scholar
- 15.Rao TS, Correa LD, Lloyd GK. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-d-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors. Neuropharmacology 1997; 36:39–50.CrossRefPubMedGoogle Scholar
- 17.Markstein R. Hydergine: interaction with the neurotransmitter systems in the central nervous system. J Pharmacol 1985; 16 Suppl 3:1–17.Google Scholar
- 34.Newall CA, Anderson LA, Philpson JD. Herbal medicine: a guide for healthcare professionals. London: The Pharmaceutical, 1996.Google Scholar
- 36.Robbers JE, Tyler VE. Tyler’s herbs of choice: the therapeutic use of phytomedicinals. New York: The Haworth Herbal Press, 1999.Google Scholar
- 42.Jussofie A, Schmiz A, Hiemke C. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology (Berl) 1994; 116:469–474.Google Scholar
- 58.Muller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 1998; 31 Suppl 1:16–21.Google Scholar